You are here

Phenacetin consumption

Document

Malignant neoplasm of the renal pelvis and ureter - Phenacetin consumption Factor

Last reviewed for CCPS 30 June 1999.

Investigative Documents

Claimant Report - Phenacetin - Malignant Neoplasm of the Renal Pelvis and Ureter [CR9115]

Medical Report - Phenacetin - Malignant Neoplasm of the Renal Pelvis and Ureter [MR9148]

Preliminary questions [23657]

23658

the veteran has consumed phenacetin in phenacetin containing preparations at some time.

23659the veteran has established the causal connection between the consumption of phenacetin in phenacetin containing preparations and VEA service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

23660the veteran has established the causal connection between the consumption of phenacetin in phenacetin containing preparations and operational service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

or

23661the veteran has established the causal connection between the consumption of phenacetin in phenacetin containing preparations and eligible service for the clinical onset of malignant neoplasm of the renal pelvis and ureter.

Clinical onset and operational service [23660]

23662

the veteran consumed a total of 50 grams of phenacetin in phenacetin containing preparations at least 10 years before the clinical onset of the condition under consideration.

23705

the veteran's consumption of a total of 50 grams of phenacetin in phenacetin containing preparations at least 10 years before the clinical onset of the condition under consideration was materially contributed to by treatment of an illness or injury which is identifiable.

23667the identified illness or injury, which made a material contribution to the veteran's consumption of phenacetin in phenacetin containing preparations, is causally related to operational service.

Clinical onset and eligible service [23661]

23668

the veteran consumed a total of 100 grams of phenacetin in phenacetin containing preparations at least 10 years before the clinical onset of the condition under consideration.

23705

the veteran's consumption of a total of 50 grams of phenacetin in phenacetin containing preparations at least 10 years before the clinical onset of the condition under consideration was materially contributed to by treatment of an illness or injury which is identifiable.

23672

the identified illness or injury made a material contribution to the veteran's consumption of a total of 100 grams of phenacetin in phenacetin containing preparations at least 10 years before the clinical onset of the condition under consideration.

23674the identified illness or injury, which made a material contribution to the veteran's consumption of phenacetin in phenacetin containing preparations, is causally related to eligible service.